UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (12315) 12315
Newspaper Article (496) 496
Newsletter (173) 173
Book Chapter (167) 167
Magazine Article (90) 90
Dissertation (9) 9
Publication (6) 6
Reference (4) 4
Web Resource (4) 4
Conference Proceeding (3) 3
Trade Publication Article (3) 3
Transcript (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (8751) 8751
science & technology (6677) 6677
life sciences & biomedicine (6478) 6478
diuretics (5892) 5892
male (5585) 5585
female (4715) 4715
middle aged (3405) 3405
diuretics - therapeutic use (3268) 3268
diuretics - administration & dosage (2992) 2992
aged (2966) 2966
adult (2527) 2527
hypertension - drug therapy (2329) 2329
animals (2188) 2188
hypertension (1858) 1858
cardiovascular system & cardiology (1707) 1707
diuretics - pharmacology (1681) 1681
drug therapy, combination (1617) 1617
heart failure (1598) 1598
abridged index medicus (1553) 1553
pharmacology & pharmacy (1440) 1440
blood pressure - drug effects (1321) 1321
treatment outcome (1310) 1310
heart failure - drug therapy (1258) 1258
cardiac & cardiovascular systems (1197) 1197
diuretics - adverse effects (1123) 1123
rats (1120) 1120
antihypertensive agents - therapeutic use (1092) 1092
blood pressure (1077) 1077
risk factors (996) 996
drug therapy (994) 994
furosemide - administration & dosage (988) 988
antihypertensive agents - administration & dosage (934) 934
time factors (922) 922
general & internal medicine (916) 916
dose-response relationship, drug (871) 871
furosemide (840) 840
aged, 80 and over (803) 803
care and treatment (776) 776
patients (774) 774
angiotensin-converting enzyme inhibitors - therapeutic use (724) 724
medicine, general & internal (723) 723
research (715) 715
analysis (707) 707
medicine & public health (704) 704
mortality (693) 693
furosemide - pharmacology (688) 688
hypertension - physiopathology (663) 663
dosage and administration (662) 662
double-blind method (660) 660
peripheral vascular disease (611) 611
health aspects (609) 609
furosemide - therapeutic use (608) 608
administration, oral (601) 601
adolescent (568) 568
adrenergic beta-antagonists - therapeutic use (566) 566
retrospective studies (563) 563
prospective studies (559) 559
heart failure - physiopathology (554) 554
urology & nephrology (552) 552
kidney - drug effects (513) 513
cardiology (512) 512
internal medicine (507) 507
urine (502) 502
clinical trials as topic (499) 499
angiotensin-converting enzyme inhibitors - administration & dosage (483) 483
hydrochlorothiazide - administration & dosage (482) 482
benzothiadiazines (481) 481
follow-up studies (475) 475
clinical trials (442) 442
diuresis - drug effects (439) 439
antihypertensive agents - adverse effects (436) 436
diabetes (434) 434
drug dosages (433) 433
drugs (417) 417
sodium chloride symporter inhibitors - therapeutic use (417) 417
studies (417) 417
hydrochlorothiazide (415) 415
hypertension - complications (414) 414
enzymes (406) 406
medicine (403) 403
sodium (403) 403
medical research (401) 401
cardiovascular disease (396) 396
sodium chloride symporter inhibitors - administration & dosage (390) 390
diuretic (386) 386
calcium channel blockers - therapeutic use (385) 385
hydrochlorothiazide - therapeutic use (382) 382
infusions, intravenous (378) 378
physiology (375) 375
acute disease (371) 371
sodium - urine (370) 370
child (369) 369
pediatrics (369) 369
prognosis (369) 369
drug combinations (365) 365
angiotensin (362) 362
drug administration schedule (361) 361
potassium (359) 359
drug interactions (358) 358
injections, intravenous (357) 357
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (12026) 12026
German (392) 392
Japanese (254) 254
French (218) 218
Russian (214) 214
Italian (104) 104
Spanish (97) 97
Portuguese (55) 55
Norwegian (37) 37
Polish (34) 34
Danish (31) 31
Chinese (26) 26
Swedish (25) 25
Czech (17) 17
Dutch (17) 17
Hungarian (14) 14
Romanian (10) 10
Lithuanian (8) 8
Bulgarian (5) 5
Finnish (5) 5
Hebrew (4) 4
Korean (4) 4
Serbian (4) 4
Turkish (4) 4
Slovak (3) 3
Ukrainian (3) 3
Indonesian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet (British edition), ISSN 0140-6736, 09/2005, Volume 366, Issue 9489, pp. 895 - 906
The apparent shortfall in prevention of coronary heart disease (CHD) noted in early hypertension trials has been attributed to disadvantages of the diuretics... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Calcium Channel Blockers - adverse effects | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Antihypertensive Agents - administration & dosage | Bendroflumethiazide - administration & dosage | Hypertension - drug therapy | Male | Perindopril - administration & dosage | Sodium Chloride Symporter Inhibitors - administration & dosage | Diuretics | Adrenergic beta-Antagonists - adverse effects | Adult | Female | Blood Pressure - drug effects | Atenolol - administration & dosage | Drug Therapy, Combination | Amlodipine - administration & dosage | Adrenergic beta-Antagonists - administration & dosage | Risk Factors | Amlodipine - adverse effects | Angiotensin-Converting Enzyme Inhibitors - administration & dosage | Antihypertensive Agents - adverse effects | Coronary Disease - prevention & control | Calcium Channel Blockers - administration & dosage | Atenolol - adverse effects | Hypertension - complications | Aged | Hypertension | Antihypertensive drugs | Evaluation | Dosage and administration | Drug therapy | Prevention | Drug therapy, Combination | Health aspects | Coronary heart disease | Risk factors | Studies | Drugs | Cardiovascular disease | Medical treatment | Myocardial infarction | Heart attacks | Antihypertensives | Clinical trials | Family medical history | Evidence-based medicine | Blood | Randomization | Motivation | Blood pressure | Heart diseases | Antihypertensive agents | Cerebral infarction | Stroke | Fasting | Mortality | Diabetes mellitus | Health risks | Triglycerides | Metabolism | Risk analysis | Atenolol | Patients | Coronary artery disease | Cholesterol | Heart rate | Infarction | Diabetes | Cardiovascular diseases | Health risk assessment | Potassium | Index Medicus | Abridged Index Medicus | Amlodipine/administration & dosage/adverse effects | Bendroflumethiazide/administration & dosage | Cardiovascular Diseases/prevention & control | Perindopril/administration & dosage | MEDICIN OCH HÄLSOVETENSKAP | Atenolol/administration & dosage/adverse effects | Combination | Antihypertensive Agents/administration & dosage/adverse effects | Angiotensin-Converting Enzyme Inhibitors/administration & dosage | MEDICAL AND HEALTH SCIENCES | Coronary Disease/prevention & control | Drug Therapy | Adrenergic beta-Antagonists/administration & dosage/adverse effects | Blood Pressure/drug effects | Hypertension/complications/drug therapy | Calcium Channel Blockers/administration & dosage/adverse effects | Sodium Chloride Symporter Inhibitors/administration & dosage
Journal Article
BMC nephrology, ISSN 1471-2369, 10/2015, Volume 16, Issue 1, pp. 158 - 158
Background: Dose adjustment for certain drugs is required in patients with reduced renal function to avoid toxicity as many drugs are eliminated by the... 
Prospective | Dose adjustment | Renal impairment | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Prospective Studies | Spironolactone - administration & dosage | Humans | Middle Aged | Fluconazole - administration & dosage | Antihypertensive Agents - administration & dosage | Male | Young Adult | Drug Dosage Calculations | Aged, 80 and over | Adult | Female | Cimetidine - administration & dosage | Enalapril - administration & dosage | Pharmaceutical Preparations - administration & dosage | Medication Errors | Severity of Illness Index | Diuretics - administration & dosage | Vancomycin - administration & dosage | Cross-Sectional Studies | Trimethoprim, Sulfamethoxazole Drug Combination - administration & dosage | Hospitalization | Acute Kidney Injury - physiopathology | Anti-Arrhythmia Agents - administration & dosage | Creatinine - urine | Renal Insufficiency, Chronic - physiopathology | Anti-Ulcer Agents - administration & dosage | Gout Suppressants - administration & dosage | Drug Prescriptions - statistics & numerical data | Allopurinol - administration & dosage | Digoxin - administration & dosage | Adolescent | Ceftazidime - administration & dosage | Creatinine - blood | Aged | Anti-Bacterial Agents - administration & dosage | Antifungal Agents - administration & dosage | Ethiopia | Drugs | Prescribing | Medical research | Hospital patients | Prescription writing | Analysis | Medicine, Experimental | Medical care | Quality management | Index Medicus
Journal Article
Archives of Dermatological Research, ISSN 0340-3696, 1/2009, Volume 301, Issue 1, pp. 99 - 105
Drug-induced lupus erythematosus (DILE) is defined as a lupus-like syndrome temporally related to continuous drug exposure which resolves after discontinuation... 
Drug-induced lupus erythematosus | Antinuclear antibodies (ANA) | Medicine & Public Health | Dermatology | Anti-TNFα-induced lupus | Anti-histone antibodies | Subacute cutaneous drug-induced lupus (SCLE) | Drug reactions | Life Sciences & Biomedicine | Science & Technology | Antifungal Agents - adverse effects | Antitubercular Agents - adverse effects | Naphthalenes - adverse effects | Antibodies - metabolism | Calcium Channel Blockers - adverse effects | Serositis | Exanthema | Humans | Isoniazid - adverse effects | Interferons - adverse effects | Antihypertensive Agents - administration & dosage | Sodium Chloride Symporter Inhibitors - adverse effects | Arthritis | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Lupus Erythematosus, Systemic - immunology | Sodium Chloride Symporter Inhibitors - administration & dosage | Tumor Necrosis Factor-alpha - immunology | Antibodies - immunology | Lupus Erythematosus, Cutaneous - chemically induced | Procainamide - administration & dosage | Lupus Erythematosus, Cutaneous - immunology | Angiotensin-Converting Enzyme Inhibitors - administration & dosage | Anti-Arrhythmia Agents - administration & dosage | Procainamide - adverse effects | Antihypertensive Agents - adverse effects | Hydralazine - adverse effects | Isoniazid - administration & dosage | Lupus Erythematosus, Systemic - diagnosis | Interferons - administration & dosage | Hydralazine - administration & dosage | Animals | Anti-Arrhythmia Agents - adverse effects | Naphthalenes - administration & dosage | Calcium Channel Blockers - administration & dosage | Antitubercular Agents - administration & dosage | Lupus Erythematosus, Systemic - chemically induced | Antifungal Agents - administration & dosage | Lupus Erythematosus, Cutaneous - diagnosis | Lupus | Antigen-antibody reactions | Enzymes | Antigens | Biological products | Antibodies | Viral antibodies | Enzyme inhibitors | Systemic lupus erythematosus | Fluocinolone acetonide | Calcium channel blockers | Diuretics | Kidney diseases | Hydralazine | Index Medicus
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 11/2013, Volume 310, Issue 23, pp. 2533 - 2543
Journal Article
by Caraceni, Paolo and Riggio, Oliviero and Angeli, Paolo and Alessandria, Carlo and Neri, Sergio and Foschi, Francesco G and Levantesi, Fabio and Airoldi, Aldo and Boccia, Sergio and Svegliati-Baroni, Gianluca and Fagiuoli, Stefano and Romanelli, Roberto G and Cozzolongo, Raffaele and Di Marco, Vito and Sangiovanni, Vincenzo and Morisco, Filomena and Toniutto, Pierluigi and Tortora, Annalisa and De Marco, Rosanna and Angelico, Mario and Cacciola, Irene and Elia, Gianfranco and Federico, Alessandro and Massironi, Sara and Guarisco, Riccardo and Galioto, Alessandra and Ballardini, Giorgio and Rendina, Maria and Nardelli, Silvia and Piano, Salvatore and Elia, Chiara and Prestianni, Loredana and Cappa, Federica Mirici and Cesarini, Lucia and Simone, Loredana and Pasquale, Chiara and Cavallin, Marta and Andrealli, Alida and Fidone, Federica and Ruggeri, Matteo and Roncadori, Andrea and Baldassarre, Maurizio and Tufoni, Manuel and Zaccherini, Giacomo and Bernardi, Mauro and Domenicali, Marco and Giannone, Ferdinando A and Merli, Manuela and Gioia, Stefania and Fasolato, Silvano and Sticca, Antonietta and Campion, Daniela and Risso, Alessandro and Saracco, Giorgio M and Maiorca, Daniela and Rizzotto, Agostino and Lanzi, Arianna and Neri, Elga and Visani, Anna and Mastroianni, Antonio and Alberti, Alberto B and Mazzarelli, Chiara and Vangeli, Marcello and Marzioni, Marco and Capretti, Francesca and Kostandini, Alba and Magini, Giulia and Colpani, Maria and Laffi, Giacomo and Gabbani, Tommaso and Marsico, Maria and Zappimbulso, Marianna and Petruzzi, Josè and Calvaruso, Vincenza and Parrella, Giovanni and Caporaso, Nicola and Auriemma, Francesco and Guarino, Maria and Pugliese, Fabio and Gasbarrini, Antonio and Leo, Pietro and De Leonardis, Francesco and Pecchioli, Alessandra and Rossi, Piera and Raimondo, Giovanni and Negri, Elisa and Dallio, Marcello and Loguercio, Carmelina and Conte, Dario and Celli, Natascia and Bringiotti, Roberto and Castellaneta, Nicola M and Salerno, Francesco and ANSWER Study Investigators
The Lancet (British edition), ISSN 0140-6736, 06/2018, Volume 391, Issue 10138, pp. 2417 - 2429
Journal Article
Diabetes (New York, N.Y.), ISSN 1939-327X, 01/2015, Volume 64, Issue 1, pp. 236 - 242
Journal Article
Trials, ISSN 1745-6215, 01/2011, Volume 12, Issue 1, pp. 3 - 3
Journal Article
Diabetes, obesity & metabolism, ISSN 1462-8902, 09/2013, Volume 15, Issue 9, pp. 853 - 862
Journal Article